NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

1 Saves · 6 Shares · 2 Comments Discussion

Grant Name

Funder

HHS-NIH11(National Institutes of Health)

Research Field

Health

Deadline

April 5, 2024

Grant Size

$1,000,000

Contact Info

National Institutes of Health grantsinfo@nih.gov

Eligibility

Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Grant Number

PAR-21-224

Description

This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Website

http://grants.nih.gov/grants/guide/pa-files/PAR-21-224.html

Funding resources
NIH General Instructions	Download File
NIH Application Guide	Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link